Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Genome-wide meta-analysis of 24 paediatric immune-mediated diseases (18,086 cases, 131,019 controls, European ancestry) found 39 non-MHC loci (15 new), 19 shared across categories, and 178 prioritised genes including 43 approved or investigational drug targets.
Meta-analysisn = 149,105
Li et al. Shared genetic architecture and therapeutic targets across paediatric immune-mediated diseasesMeta-analysis of 92 observational studies (60,816 adults): ulcers without H. pylori or NSAID use made up 13.0% of peptic ulcer disease, 11.3% of bleeding and 22.0% of perforated ulcers; exploratory analyses suggest a rise over time in bleeding PUD.
Meta-analysisn = 60,816
Watanabe et al. Meta-Analysis: Prevalence of Non-Helicobacter pylori, Non-NSAID Peptic Ulcer DiseaseSystematic review of 44 studies (n=18,071) in AL amyloidosis: pooled sensitivity was 0.68 for serum immunofixation, 0.77 urine immunofixation, 0.82 sFLC ratio, and 0.99 (95% CI 0.96-1.00) with all three combined (10 studies, n=1430).
Meta-analysisn = 18,071
Azzam et al. Diagnostic utility of immunofixation and free light chain assay in AL amyloidosis: a systematic review and meta-analysisMeta-analysis of 4 phase III trials (17,748 participants) of adjuvant CDK4/6 inhibitors in HR+/HER2− early breast cancer: iDFS benefit was similar in pre-/peri-menopausal (HR 0.80) and postmenopausal (HR 0.79) patients; no significant subgroup difference for iDFS or OS.
Meta-analysisn = 17,748
Bender et al. The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trialsSystematic review of 25 RCTs in localised renal cell carcinoma (13 trials, 9594 patients, meta-analysed): trial-level DFS correlated strongly with overall survival (r 0.75; R² 0.57); a DFS HR <0.914 predicted an OS benefit, supporting DFS as a surrogate end point.
Meta-analysisn = 9,594
Martinez et al. Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysisMeta-analysis of 10 studies (2430 high-performance athletes, 2725 non-athletes): no significant difference in prevalence of at least mild depressive symptoms (OR 1.016, 95% CI 0.815 to 1.267). Males in both groups were less likely than females to report symptoms.
Meta-analysisn = 5,155
Gorczynski et al. Depressive symptoms in high-performance athletes and non-athletes: a comparative meta-analysis updateMeta-analysis of 55 cohorts (4630 patients with multiple myeloma) after BCMA CAR-T: pooled non-ICANS neurological toxicity was 0.81% (95% CI 0.37-1.77%), higher with cilta-cel than ide-cel (4.6% vs 0.5%); cranial nerve palsies were commonest.
Meta-analysisn = 4,630
van Besien et al. Non-ICANS neurologic toxicity after BCMA CAR-T therapy: a systematic review and meta-analysis of 4630 patients with multiple myelomaSystematic review of 10 RCTs (5 meta-analysed; 2235 vs 1409 patients) in elderly patients with chronic insomnia: dual orexin receptor antagonists improved sleep latency, wake after sleep onset and total sleep time vs placebo; lemborexant and suvorexant had more adverse events.
Meta-analysisn = 3,644
Rollo et al. Treatment of chronic insomnia in elderly adults with dual orexin receptor antagonists: a systematic review and meta-analysisNetwork meta-analysis of 26 studies (3298 children) of pyeloplasty for PUJ obstruction: overall complications did not differ between JJ, external or no stent; stents were associated with less major leakage (OR 0.20), JJ with more UTI. Evidence mostly low certainty.
Meta-analysisn = 3,298
Aubert et al. The optimal stent-strategy in paediatric pyeloplasty: a systematic review and network meta-analysisMeta-analysis of 27 observational studies (3,162 patients) with acute upper limb ischaemia: pooled success 90.1% for surgery, 71.8% endovascular, 79.4% anticoagulation alone; high heterogeneity, all high risk of bias, low to very low certainty; no valid comparison possible.
Meta-analysisn = 3,162
Lee et al. A Systematic Review and Meta-Analysis of Reported Success and Complication Outcomes the Management of Acute Upper Limb Ischemia